Join our Healthy Volunteer Studies
We're looking for healthy adults to take part in upcoming research studies in Brisbane! These studies are essential in helping researchers develop new treatments and medications.
Critical Eligibility Criteria:
To take part in this study, you will need to meet all the following:
- 18 to 65 years of age
- Able to commit to study schedules
- No uncontrolled or serious diseases
Please note, additional eligibility criteria will apply
Commitment:
Each study has varying commitments please see the Study Guide below for specific details.
Locations:
Brisbane
If you take part in this research study, there will be:
Reimbursement of costs
For out-of-pocket expenses, such as time, travel and parking.
Free study-related medical care
Be among the first to access potential new research treatments before they are widely available.
Expert medical monitoring
Receive top-tier medical care and monitoring from experienced healthcare professionals.
Contribution to medical research
Help investigate a potential new treatment that could improve the lives of individuals with Panic Disorder
Register your interest now
or scroll down to read the study FAQs
Study Guide
01
Gut Health Study
-
Reimbursement
$8,600
Stay Duration
4 nights
Study Length:
360 days
What is the study about?
Inflammatory diseases like Ulcerative Colitis and Crohn's Disease cause the immune system to attack itself, leading to inflammation and tissue damage. Current treatments may not fully address the underlying biological processes contributing to these symptoms.
Volunteer Requirements:
- Aged 18-65 years old
- No significant medical history
- Not taking any prescription medication (except for contraception)
- Non-smoker or smoking less than 5 cigarettes per week and willing to pause smoking for the duration of the trial.
02
Immune-Medicated Disease Study
+
$7,850
Stay Duration:
2x5 night inpatient stay
Study Length:
72 days
What is the study about?
We are conducting a clinical trial to evaluate a potential new treatment for immune-mediated diseases in healthy participants. This study aims to assess the safety, tolerability, and how the body absorbs and processes the potential new treatment.
The investigational treatment is being developed to potentially help manage immune-mediated diseases by inhibiting a specific enzyme, which reduces the activity of certain immune cells. This study builds on previous data and aims to explore higher doses and the effect of food on the treatment's absorption to optimize its safety and effectiveness.
Volunteer Requirements:
- 18-60 years old
- No significant medical history
- Not taking any prescription medication (except for contraception)
- Non-smoker
- Willing to abstain from alcohol, grapefruit and certain medications.
03
Expression Study
+
Reimbursement:
$10,020
Stay Duration:
5 nights & 1 overnight stay
Study length:
85 days
What is the study about?
Autoimmune diseases can significantly impact quality of life, often requiring immunosuppressive therapies that come with serious side effects and long-term health risks. This study is evaluating a potential new treatment designed to target CD28 and OX40 pathways, aiming to regulate the immune system more precisely and effectively.
Volunteer Requirements:
- 18-55 years old
- Weight: Males: 50-110kg, Females: 40-90kg
- Not taking any prescription medication (except for contraception)
- Non-smoker or smoking less than 1 cigarettes/day, using less than 10 mg nicotine/day (including vaping or patches) and willing to pause smoking for the duration of the trial.
04
Compliment Study
+
Reimbursement:
$11,490
Stay Duration:
1x9 nights, 2x2 nights & 1x5 nights
Study Length:
99 days
What is the study about?
This study is evaluating a new potential treatment for complement-mediated diseases. The complement system is a part of our immune system that helps protect us from infections. This study aims to assess the safety, tolerability, and pharmacokinetics (PK) of multiple subcutaneous (SC) doses in healthy participants. Currently, there are limited approved treatment options for diseases like Paroxysmal Nocturnal Hemoglobinuria (PNH) and other complement-mediated diseases.
The study will measure how the medication moves and works in the body, including certain blood levels and effects. This initial phase is crucial before testing in individuals with these diseases. The drug has been tested before, and this study will use doses from that previous research.
Volunteer Requirements:
- 18-55 years old
- Not taking any prescription medication (except for contraception)
- Non-smoker or smoking less than 10 cigarettes per week and willing to pause smoking for the duration of the trial.
05
Who are sponsoring these studies?
+
This study is being sponsored by Nucleus Network.
06
Where the study site?
+
07
What if I have other questions about the study?
+
We are here for you! Head to our Evrima Help Centre and search for answers relating to clinical trials, study information and managing your Evrilink account
This study has been approved by an independent Human Research Ethics Committee
Help make medical research breakthroughs happen.
Need help with clinical trial information?
Search our Evrima help Centre for answers related to information about our active studies, information about managing your Evrilink account, and general clinical trial knowledge!
Read our FAQs